Ifp Advisors, Inc Cerus Corp Transaction History

Ifp Advisors, Inc

$2.91 Billion
Q4 2024

A detailed history of Ifp Advisors, Inc transactions in Cerus Corp stock. As of the latest transaction made, Ifp Advisors, Inc holds 88 shares of CERS stock, worth $162. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Holding current value

$162

% of portfolio

0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 04, 2025	BUY	$1.52 - $2.03 $133 - $178	88 New	88 $0
Q3 2021 Oct 06, 2021	SELL	$4.79 - $6.68 $0 - $0	0 Closed	0 $0
Q2 2021 Jul 13, 2021	BUY	$5.35 - $6.35 $0 - $0	0 New	0 $0
Q1 2021 Apr 30, 2021	BUY	$5.68 - $7.87 $0 - $0	0 New	0 $0
Q4 2020 Jan 25, 2021	BUY	$5.25 - $8.56 $0 - $0	0 New	0 $0
Q3 2020 Oct 29, 2020	BUY	$5.78 - $7.47 $0 - $0	0 New	0 $0
Q2 2020 Aug 05, 2020	BUY	$4.5 - $7.02 $0 - $0	0 New	0 $0
Q1 2020 May 12, 2020	BUY	$2.87 - $5.49 $0 - $0	0 New	0 $0
Q4 2019 Jan 17, 2020	BUY	$3.84 - $4.86 $0 - $0	0 New	0 $0
Q3 2019 Nov 07, 2019	BUY	$4.86 - $6.05 $0 - $0	0 New	0 $0
Q3 2018 Oct 25, 2018	SELL	$6.89 - $7.78 $7,427 - $8,386	-1,078 Closed	0 $0
Q2 2018 Aug 07, 2018	BUY	$5.19 - $7.25 $5,594 - $7,815	1,078 New	1,078 $0
Q3 2017 Oct 30, 2017	SELL	$2.22 - $2.73 $222 - $273	-100 Closed	0 $0
Q2 2016 Jun 03, 2019	BUY	N/A	100	100 $1,000

Others Institutions Holding CERS

# of Institutions

160

Shares Held

144M

Call Options Held

22.5K

Put Options Held

23.6K

Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

20.8M
Shares

$38.5 Million
0.28% of portfolio
Baker Bros. Advisors LP New York, NY

19.5M
Shares

$36 Million
0.33% of portfolio
Black Rock Inc. New York, NY

13.9M
Shares

$25.7 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

10.4M
Shares

$19.3 Million
0.0% of portfolio
Wasatch Advisors Inc Salt Lake City, UT

8.32M
Shares

$15.4 Million
0.06% of portfolio

View Full List

About CERUS CORP

Ticker CERS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 177,090,000
Market Cap $328M
Description
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...

More about CERS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.

Account